Cargando…

Frequent coexistence of anti-topoisomerase I and anti-U1RNP autoantibodies in African American patients associated with mild skin involvement: a retrospective clinical study

INTRODUCTION: The presence of anti-topoisomerase I (topo I) antibodies is a classic scleroderma (SSc) marker presumably associated with a unique clinical subset. Here the clinical association of anti-topo I was reevaluated in unselected patients seen in a rheumatology clinic setting. METHODS: Sera f...

Descripción completa

Detalles Bibliográficos
Autores principales:	Satoh, Minoru, Krzyszczak, Malgorzata E, Li, Yi, Ceribelli, Angela, Ross, Steven J, Chan, Edward KL, Segal, Mark S, Bubb, Michael R, Sobel, Eric S, Reeves, Westley H
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2011
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3218882/ https://www.ncbi.nlm.nih.gov/pubmed/21569292 http://dx.doi.org/10.1186/ar3334

Ejemplares similares

A new immunoprecipitation-real time quantitative PCR assay for anti-Th/To and anti-U3RNP antibody detection in systemic sclerosis
por: Ceribelli, Angela, et al.
Publicado: (2012)

Atypical clinical presentation of a subset of patients with anti-RNA polymerase III - non-scleroderma cases associated with dominant RNA polymerase I reactivity and nucleolar staining
por: Ceribelli, Angela, et al.
Publicado: (2011)

Elevated signal transducers and activators of transcription 1 correlates with increased C-C motif chemokine ligand 2 and C-X-C motif chemokine 10 levels in peripheral blood of patients with systemic lupus erythematosus
por: Dominguez-Gutierrez, Paul R, et al.
Publicado: (2014)

Reduced levels of CCL2 and CXCL10 in systemic lupus erythematosus patients under treatment with prednisone, mycophenolate mofetil, or hydroxychloroquine, except in a high STAT1 subset
por: Dominguez-Gutierrez, Paul R, et al.
Publicado: (2014)

Role of environmental factors in autoantibody production - importance of a detailed analysis in a small cohort
por: Satoh, Minoru, et al.
Publicado: (2012)

Interleukin 6 Dependence of Anti-DNA Antibody Production: Evidence for Two Pathways of Autoantibody Formation in Pristane-induced Lupus
por: Richards, Hanno B., et al.
Publicado: (1998)

Autoantibodies to transcription intermediary factor (TIF)1β associated with dermatomyositis
por: Satoh, Minoru, et al.
Publicado: (2012)

Autoantibodies against the replication protein A complex in systemic lupus erythematosus and other autoimmune diseases
por: Yamasaki, Yoshioki, et al.
Publicado: (2006)

Anti-MJ/NXP-2 autoantibody specificity in a cohort of adult Italian patients with polymyositis/dermatomyositis
por: Ceribelli, Angela, et al.
Publicado: (2012)

Upregulated miR-146a expression in peripheral blood mononuclear cells from rheumatoid arthritis patients
por: Pauley, Kaleb M, et al.
Publicado: (2008)

Autoantibodies as biomarkers for interstitial lung disease in idiopathic inflammatory myositis and systemic sclerosis: The case of anti-eIF2B antibodies
por: Ceribelli, Angela, et al.
Publicado: (2020)

U2 snRNP Is Required for Expression of the 3′ End of Genes
por: Koga, Mitsunori, et al.
Publicado: (2014)

Parallel sets of autoantibodies in MRL-lpr/lpr mice. An anti-DNA, anti- SmRNP, anti-gp70 network
Publicado: (1987)

Rpp25 is a major target of autoantibodies to the Th/To complex as measured by a novel chemiluminescent assay
por: Mahler, Michael, et al.
Publicado: (2013)

Genomic Regions Targeted by DNA Topoisomerase IIβ Frequently Interact With a Nuclear Scaffold/Matrix Protein hnRNP U/SAF‐A/SP120
por: Miyaji, Mary, et al.
Publicado: (2015)

Increased expression of FcγRI/CD64 on circulating monocytes parallels ongoing inflammation and nephritis in lupus
por: Li, Yi, et al.
Publicado: (2009)

Rapid serological detection of autoantibodies associated with Sjögren's syndrome
por: Burbelo, Peter D, et al.
Publicado: (2009)

Anti-DNA topoisomerase I autoantibodies bind directly to the cell surface of fibroblasts in patients with systemic sclerosis
por: Senécal, J-L, et al.
Publicado: (2004)

Presence of anti-RNP-A and anti-RNP-C antibodies is inversely associated with renal symptoms of systemic lupus erythematosus
por: Hoffman, I, et al.
Publicado: (2003)

Autoimmune targeting of key components of RNA interference
por: Jakymiw, Andrew, et al.
Publicado: (2006)

Monocyte surface expression of Fcγ receptor RI (CD64), a biomarker reflecting type-I interferon levels in systemic lupus erythematosus
por: Li, Yi, et al.
Publicado: (2010)

Quantification of Antifibrillarin (anti-U3 RNP) Antibodies: A New Insight for Patients with Systemic Sclerosis
por: Benyamine, Audrey, et al.
Publicado: (2021)

Doubtful Clinical Value of Subtyping Anti-U1-RNP Antibodies Regarding the RNP-70 kDa Antigen in Sera of Patients with Systemic Lupus Erythematosus
por: Ahmad, Awais, et al.
Publicado: (2023)

Reduced IgG anti-small nuclear ribonucleoprotein autoantibody production in systemic lupus erythematosus patients with positive IgM anti-cytomegalovirus antibodies
por: Palafox Sánchez, Claudia Azucena, et al.
Publicado: (2009)

Anti-hnRNP B1 (RA33) Autoantibodies Are Associated with the Clinical Phenotype in Russian Patients with Rheumatoid Arthritis and Systemic Sclerosis
por: Maslyanskiy, Aleksey, et al.
Publicado: (2014)

Anti-RNP positivity in primary Sjögren’s syndrome is associated with a more active disease and a more frequent muscular and pulmonary involvement
por: Abbara, Salam, et al.
Publicado: (2019)

Mechanisms of Autoantibody Production in Systemic Lupus Erythematosus
por: Han, Shuhong, et al.
Publicado: (2015)

Antigen Reactivity and Clinical Significance of Autoantibodies Directed Against the Pyruvate Dehydrogenase Antigen Complex in Patients With Connective Tissue Disease
por: Ceribelli, Angela, et al.
Publicado: (2022)

Molecular basis of differential 3′ splice site sensitivity to anti-tumor drugs targeting U2 snRNP
por: Vigevani, Luisa, et al.
Publicado: (2017)

Association of Anti–Topoisomerase I Antibodies of the IgM Isotype With Disease Progression in Anti–Topoisomerase I–Positive Systemic Sclerosis
por: Boonstra, Maaike, et al.
Publicado: (2020)

A cell-based assay for detection of anti-fibrillarin autoantibodies with performance equivalent to immunoprecipitation
por: Keppeke, Gerson Dierley, et al.
Publicado: (2022)

The architecture of the spliceosomal U4/U6.U5 tri-snRNP
por: Nguyen, Thi Hoang Duong, et al.
Publicado: (2015)

Structure of the spliceosomal U4 snRNP core domain and its implication for snRNP biogenesis
por: Leung, Adelaine K. W., et al.
Publicado: (2011)

TSSC4 is a component of U5 snRNP that promotes tri-snRNP formation
por: Klimešová, Klára, et al.
Publicado: (2021)

Coexistence of anti-topoisomerase I and anticentromere antibodies in a patient with systemic sclerosis. Efficacy of treatment combining rituximab and nintedanib. A case report
por: Montolio-Chiva, Lydia, et al.
Publicado: (2022)

Electron microscopy of U4/U6 snRNP reveals a Y-shaped U4 and U6 RNA containing domain protruding from the U4 core RNP
Publicado: (1991)

Prospects of Topoisomerase Inhibitors as Promising Anti-Cancer Agents
por: Yakkala, Prasanna Anjaneyulu, et al.
Publicado: (2023)

Do not confuse anti-LW autoantibodies with anti-D
por: Miola, Marcos Paulo, et al.
Publicado: (2013)

Nuclear exchange of the U1 and U2 snRNP-specific proteins
Publicado: (1990)

Anti-rods/rings autoantibody seropositivity does not affect response to telaprevir treatment for chronic hepatitis C infection
por: Calise, S. John, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_qkj1l9l2p68b2lkg9cc1u39po6